Chapel Hill CRS (3201) — Chapel Hill, North Carolina

Chapel Hill CRS (3201) is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Chapel Hill CRS (3201) has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: HIV Infections, HIV I Infection, Tenofovir.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chapel Hill CRS (3201)?

Chapel Hill CRS (3201) has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chapel Hill CRS (3201) conducted?

Chapel Hill CRS (3201) has 3 clinical trials on record, with 1 currently active. Their work covers HIV Infections, HIV I Infection, Tenofovir.

Is Chapel Hill CRS (3201) accredited by Crixeo Health?

Chapel Hill CRS (3201) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chapel Hill CRS (3201)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.